Back

Impact of optimized medical therapy on ICD shocks and survival in heart failure patients

19 May 2025 (09:00 - 10:08)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment (2) Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Patricia Bernardes

Hospital Sao Bernardo, Setubal (Portugal)

6 More presentations in this session

Presentation thumbnail
Evaluating superresponse in CRT: a clinical edge or just a remodeling effect?
Doctor S. Andraz (Faro, PT)
Abstract Slides Video
Presentation thumbnail
Alert rate characteristics of a dynamic multiparameter heart failure risk score in a real-world cohort: results from the TriageHF Post Approval Study
Doctor C. Love (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
The additional value of sacubitril/valsartan in fusion pacing CRT
Doctor A. Faur (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
home-based digital cardiac rehabilitation following step down from the acute heart failure virtual ward
Doctor R. Sankaranarayanan (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Incidence of ventricular arrhythmias in ICD patients after improvement of left ventricular ejection fraction: a longitudinal study
Doctor J. Quintal (Setubal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment (2)

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter defibrillators in heart failure with reduced ejection fraction: evaluating efficacy in the era of contemporary pharmacotherapy
thumbnail
Congress Presentation
Impact of defibrillators on mortality in patients with quadruple guideline-directed medical therapy: a propensity score-matched study
thumbnail
Congress Presentation
Clinical outcomes of implantable cardioverter defibrillators in heart failure: a comparative analysis between ischemic and non-ischemic cardiomyopathy patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources